Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000549212 | SCV000659729 | likely benign | Dilated Cardiomyopathy, Dominant | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004024431 | SCV004897150 | uncertain significance | not specified | 2021-09-27 | criteria provided, single submitter | clinical testing | The c.29C>T (p.A10V) alteration is located in exon 1 (coding exon 1) of the LRRC10 gene. This alteration results from a C to T substitution at nucleotide position 29, causing the alanine (A) at amino acid position 10 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004705672 | SCV005216126 | likely benign | not provided | criteria provided, single submitter | not provided |